Channel:  Aligning Science Across Parkinson's (ASAP)

529 Articles

Most recent first Previous |  Page 6: Articles 51-60  | Next

Cortical synaptic vulnerabilities revealed in a α-synuclein aggregation model of Parkinson's disease
Sah, S., Sauerbeck, A. D., Gupta, J., Perez-Acuna, D., Reiber, J. E., Russell, D., Goralski, T., Henderson, M., Volpicelli-Daley, L. A., Higley, M. J., Kummer, T. T., Biederer, T.
10.1101/2024.06.20.599774 — Posted: 2026-05-08
Utilizing Intraindividual Cognitive Variability to Predict Stage 2 Neuronal Synuclein Disease Progression
Combs, H. L., Kurth, R., Nair, A., York, M. K., Weintraub, D., Lafontant, D.-E., Caspell-Garcia, C., and the Parkinson's Progression Markers Initiative
10.1101/2025.10.21.25338482 — Posted: 2026-05-01
A Versatile AAV-TH-SNCA Model to Study Early α-Synuclein Pathology and Intervention
Marciano, S., Velazquez, L. G., Rodriguez Lopez, C., De Silva, N., Sommer, G., Tower, W., Torrres, E. R. S., Kaplitt, M. G., Milner, T. A., Marongiu, R.
10.64898/2026.03.20.712963 — Posted: 2026-04-30
Single cell eQTL mapping reveals convergent glial-neuronal risk architecture in Parkinson's disease
Lin, Z., Parker, J., Nithianandam, V., Mathivanan, S., Wang, T., Liao, Z., Simmons, S. K., Tuncali, I., Adiconis, X., Haywood, N., Weykopf, B., Teng, X., Sharma, M., Yuan, J., Baecher-Allan, C., Dong, X., Beach, T. G., Serrano, G. E., Levin, J. Z., Zhang, S., Feany, M. B., Scherzer, C. R.
10.64898/2026.04.24.720642 — Posted: 2026-04-29
Astrocytes mediate the dopaminergic modulation of tonic GABAergic signaling in substantia nigra
Simmons, D. V., Moreno-Ramos, O. A., Raj, D. D. A., Kaganovsky, K., Pamukcu, A., Vrieler, N., Tkatch, T., Xie, Z., Zampese, E., De Sousa, A. I. S., Ding, J., Awatramani, R. V., Wilson, C., Surmeier, D. J.
10.1101/2024.03.27.586699 — Posted: 2026-04-17
LRRK2 mutations block NCOA4 trafficking upon iron overload leading to ferroptotic death
Goldman, A., Nguyen, M., Lanoix, J., Li, C., Fahmy, A., Zhong Xu, Y., Schurr, E., Thibault, P., Desjardins, M., McBride, H.
10.1101/2025.08.25.672135 — Posted: 2026-04-17
Modeling cis-regulatory variation in human brain enhancers across a large Parkinson's Disease cohort
Sigalova, O. M., Pancikova, A., De Man, J., Theunis, K., Hulselmans, G. J., Konstantakos, V., Stuyven, B., De Brabandere, A., Geurts, J., Mikorska, A., Mukherjee, S., Abouelasrar Salama, S., Vandereyken, K., Davie, K., Mahieu, L., Adler, C. H., Beach, T. G., Serrano, G. E., Voet, T., Demeulemeester, J., Aerts, S.
10.64898/2026.03.15.711881 — Posted: 2026-04-16
Myeloid-Driven Inflammation in Prodromal Parkinson's Disease
Yasumizu, Y., Deerhake, M. E., Moon, J., Buitrago-Pocasangre, N., Russo, A., Wang, H., Zhu, B., Seibyl, J. P., Reddy, V., Wang, Q., Neish, K. J., Spillantini, M. G., Posner, D. A., Clatworthy, M., Sumida, T. S., Longbrake, E. E., Cedarbaum, J. M., Zhang, L., Hafler, D. A.
10.1101/2025.05.16.654530 — Posted: 2026-04-14
ATP13A2 Loss of Function-Driven Polyamine Dysregulation Induces SAM Depletion and Epigenetic Astrocyte Toxicity
Coccia, E., Morrone Parfitt, G., Ijaz, S., Sati, A., Gesner, J., Perez Arevalo, A., Strong, J., Bright, A., Sohail, S., Meimoun, T., Ahfeldt, T., Vangheluwe, P., Blanchard, J.
10.64898/2026.04.02.716164 — Posted: 2026-04-06
Neural cell state modulation by PARK2 and dopaminergic neuroprotection by small molecule Parkin agonism
Gong, Y., Bayati, A., Alban, T. J., Parthasarathy, P., Zhou, F., Makarov, V., Zhao, Y., Su, C., Schumacher, J. G., Singh, V., Volpicelli-Daley, L. A., Luo, W., Durcan, T. M., Dutta, S., Schwarzschild, M. A., Johnston, J. A., Chan, T. A., Chen, X.
10.64898/2026.04.01.715918 — Posted: 2026-04-04

RSS  Channel RSS